Kevin Charles Gorman, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 19,226 shares at $120.38 ($2.3M) on 2025-05-27, disclosed to the SEC on 2025-05-29.
Scheduled sale ($2.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.38 | 9,613 | $1.2M | 50.0% |
| 2 | $120.38 | 9,613 | $1.2M | 50.0% |
| Total | $120.38 avg | 19,226 | $2.3M | 100% |
| Filing → |
| NBIX | SELL | 2025-08-11 | $26.9M | — | Filing → |
| XNCR | SELL | 2025-06-16 | $29K | — | Filing → |
| NBIX | SELL | 2025-02-14 | $1.4M | — | Filing → |